Global Antibody Therapeutics and Blood Antibody Therapeutics Market Insights and Forecast to 2028

Report ID: 1240531 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 IgG1
        1.2.3 IgG4
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Autoimmune
        1.3.3 Tumor
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2017-2028)
    2.2 Antibody Therapeutics and Blood Antibody Therapeutics Growth Trends by Region
        2.2.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
        2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
        2.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
        2.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
        2.3.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue
        3.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
    3.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio
        3.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2021
    3.5 Antibody Therapeutics and Blood Antibody Therapeutics Key Players Head office and Area Served
    3.6 Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service
    3.7 Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Type
    4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2023-2028)
5 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Application
    5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
    6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
        6.2.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
    6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
        6.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
    6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
        6.4.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
    7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
        7.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
        7.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
        7.4.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
    9.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
        9.2.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
        9.3.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
        9.4.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Abbvie
        11.2.1 Abbvie Company Details
        11.2.2 Abbvie Business Overview
        11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.2.5 Abbvie Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Developments
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.5.5 Novartis Recent Developments
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.6.5 Merck Recent Developments
    11.7 Alexion Pharmaceuticals
        11.7.1 Alexion Pharmaceuticals Company Details
        11.7.2 Alexion Pharmaceuticals Business Overview
        11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.7.5 Alexion Pharmaceuticals Recent Developments
    11.8 Takeda
        11.8.1 Takeda Company Details
        11.8.2 Takeda Business Overview
        11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.8.5 Takeda Recent Developments
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.9.5 Amgen Recent Developments
    11.10 Biogen
        11.10.1 Biogen Company Details
        11.10.2 Biogen Business Overview
        11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.10.5 Biogen Recent Developments
    11.11 UCB
        11.11.1 UCB Company Details
        11.11.2 UCB Business Overview
        11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.11.5 UCB Recent Developments
    11.12 Eli Lilly and Company
        11.12.1 Eli Lilly and Company Company Details
        11.12.2 Eli Lilly and Company Business Overview
        11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.12.5 Eli Lilly and Company Recent Developments
    11.13 AstraZeneca
        11.13.1 AstraZeneca Company Details
        11.13.2 AstraZeneca Business Overview
        11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
        11.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
        11.13.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of IgG1
    Table 3. Key Players of IgG4
    Table 4. Key Players of Others
    Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2023-2028)
    Table 11. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
    Table 12. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
    Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
    Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
    Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2021)
    Table 18. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service
    Table 22. Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Roche Company Details
    Table 63. Roche Business Overview
    Table 64. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 65. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Roche Recent Developments
    Table 67. Abbvie Company Details
    Table 68. Abbvie Business Overview
    Table 69. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 70. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Abbvie Recent Developments
    Table 72. Johnson & Johnson Company Details
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 75. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Johnson & Johnson Recent Developments
    Table 77. Bristol-Myers Squibb Company Details
    Table 78. Bristol-Myers Squibb Business Overview
    Table 79. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 80. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Bristol-Myers Squibb Recent Developments
    Table 82. Novartis Company Details
    Table 83. Novartis Business Overview
    Table 84. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 85. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Novartis Recent Developments
    Table 87. Merck Company Details
    Table 88. Merck Business Overview
    Table 89. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 90. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Merck Recent Developments
    Table 92. Alexion Pharmaceuticals Company Details
    Table 93. Alexion Pharmaceuticals Business Overview
    Table 94. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 95. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Alexion Pharmaceuticals Recent Developments
    Table 97. Takeda Company Details
    Table 98. Takeda Business Overview
    Table 99. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 100. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Takeda Recent Developments
    Table 102. Amgen Company Details
    Table 103. Amgen Business Overview
    Table 104. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 105. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Amgen Recent Developments
    Table 107. Biogen Company Details
    Table 108. Biogen Business Overview
    Table 109. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 110. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 111. Biogen Recent Developments
    Table 112. UCB Company Details
    Table 113. UCB Business Overview
    Table 114. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 115. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 116. UCB Recent Developments
    Table 117. Eli Lilly and Company Company Details
    Table 118. Eli Lilly and Company Business Overview
    Table 119. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 120. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 121. Eli Lilly and Company Recent Developments
    Table 122. AstraZeneca Company Details
    Table 123. AstraZeneca Business Overview
    Table 124. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
    Table 125. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 126. AstraZeneca Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. IgG1 Features
    Figure 3. IgG4 Features
    Figure 4. Others Features
    Figure 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Autoimmune Case Studies
    Figure 7. Tumor Case Studies
    Figure 8. Others Case Studies
    Figure 9. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
    Figure 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2021
    Figure 16. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 20. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 26. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Region (2017-2028)
    Figure 36. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 56. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 60. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 61. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 62. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 63. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 64. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 65. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 66. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 67. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Frequently Asked Questions
Antibody Therapeutics and Blood Antibody Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antibody Therapeutics and Blood Antibody Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antibody Therapeutics and Blood Antibody Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ceiling Grid System

Ceiling Grid System market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Bathtubs and Showers

Bathtubs and Showers market is segmented by Type and by Application. Players, stakeholders, and o ... Read More